A Clinical Study to Observe the Effectiveness and Safety of IBI310, Bevacizumab Combined With Sintilimab in the Treatment of Advanced Hepatocellular Carcinoma
Clinical trial NCT05363722 · UNKNOWN
Trial details
- NCT number
- NCT05363722
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-01
- Primary completion
- 2023-04-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.